[Federal Register Volume 75, Number 17 (Wednesday, January 27, 2010)]
[Notices]
[Pages 4408-4409]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-1570]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Public Meeting

    The Centers for Disease Control and Prevention (CDC), Food and Drug 
Administration (FDA), and National Institutes of Health (NIH) announce 
a public meeting to obtain public comment on ``A Public Health Action 
Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues)''.
    Time and Date: 12-1:30 p.m. EST, February 3, 2010.
    Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, 
Maryland 20814 (One Bethesda Metro Center).
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 200 people.
    Purpose: The purpose of the meeting is to present the annual report 
of

[[Page 4409]]

progress by Federal agencies in accomplishing activities outlined in 
``A Public Health Action Plan to Combat Antimicrobial Resistance (Part 
I: Domestic Issues)'' and obtain comments from the public regarding the 
annual report. ``The Action Plan'' serves as a blueprint for activities 
of Federal agencies to address the issue of antimicrobial resistance. 
The focus of the plan is on domestic issues. A copy of the plan and 
annual report can be found at http://www.cdc.gov/drugresistance/actionplan/index.htm.
    Matters to be Discussed: The agenda will consist of welcome and 
introductory comments, executive summary (including a progress report 
on revising the Action Plan) and brief reports in each of four focus 
areas: Surveillance, Prevention and Control, Research, and Product 
Development. A general discussion will follow the brief reports.
    Comments and suggestions from the public for the Federal agencies 
related to each of the focus areas will be taken under advisement by 
the Antimicrobial Resistance Interagency Task Force. The agenda does 
not include development of consensus positions, guidelines, or 
discussions or endorsement of specific commercial products.
    Limited time will be available for oral questions, comments and 
suggestions from the public. Depending on the number of individuals 
wishing to comment, a time limit of three minutes per individual may be 
imposed. In the interest of time, visual aids will not be permitted, 
although written material may be submitted for subsequent review by the 
Task Force. Persons who anticipate attending the meeting are asked to 
send written notification to the contact person below by January 28, 
2010. Notification information should include name, organization (if 
applicable), address, phone number, fax number, and e-mail address.
    Written comments and suggestions from the public are also 
encouraged and may be submitted to the contact person or email listed 
below but must be submitted for consideration no later than March 31, 
2010.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Marsha A. Jones, Office of 
Antimicrobial Resistance, National Center for Emerging and Zoonotic 
Infectious Diseases (proposed), Centers for Disease Control and 
Prevention, 1600 Clifton Road, NE., Mailstop A-07, Atlanta, Georgia 
30333; telephone: 404-639-4052; fax 404-718-2147; e-mail 
[email protected].

SUPPLEMENTARY INFORMATION: ``The Public Health Action Plan to Combat 
Antimicrobial Resistance'' (Action Plan) was developed by the 
Interagency Task Force on Antimicrobial Resistance. The Task Force, 
created in 1999, is co-chaired by the Centers for Disease Control and 
Prevention (CDC), the Food and Drug Administration (FDA), and the 
National Institutes of Health (NIH). Other Federal agencies that are 
members of the Task Force include the Agency for Healthcare Research 
and Quality (AHRQ), Centers for Medicare and Medicaid Services (CMS), 
the Health Resources and Services Administration (HRSA), the Department 
of Agriculture (USDA), the Department of Defense (DoD), the Department 
of Veterans Affairs (VA), and the Environmental Protection Agency 
(EPA).
    The Action Plan reflects a broad-based consensus of Federal 
agencies on actions needed to address antimicrobial resistance. Input 
from State and local health agencies, universities, professional 
organizations, pharmaceutical companies, health care delivery 
organizations, agricultural producers, consumer groups, and other 
members of the public was important in developing the plan. While some 
actions are already underway, complete implementation of this plan will 
require close collaboration with all of these partners, which is a 
major objective of this process.
    The 2001 Action Plan is under revision and is expected to be 
completed in 2010. Upon completion, the revised Action Plan will be 
available for public comment.

    Dated: January 20, 2010.
Tanja Popovic,
Chief Science Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-1570 Filed 1-26-10; 8:45 am]
BILLING CODE 4163-18-P